Moreover, we further predicted the prognostic values of these genes associated with OS in BC patients with different stages, ages, molecular subtypes, ER/PR/HER2 status, TNM status, and TP53 mutation status, in addition to their expression levels using Cox Proportional‐Hazards model based on TCGA cohorts. This evidence concerns the gene ESR1 and breast cancer.